AriBio said Tuesday that it has filed an IND (investigational new drug) application with the U.S. Food and Drug Administration for a phase 3 clinical trial of its oral dementia treatment, AR1001.AriBio added that it is developing AR1001 as a multi-effect dementia treatment that suppresses dementia p
HK Inno.N said on Wednesday that its gastroesophageal reflux drug, K-CAB (ingredient: tegoprazan) obtained approval from the Indonesian National Agency of Drug and Food Control (NADFC) on Oct. 7, following approvals in Mongolia, China, and the Philippines.K-CAB, Korea's 30th novel drug, is a new pot
Korea Public Tissue Bank (KPTB), a public institution under the Ministry of Health and Welfare, which produces transplant materials by receiving donated human tissues, was caught red-handed for selling off donated tissue at a discount price, a lawmaker said.According to the special audit result repo
Korea reported 10 deaths from Covid-19 on Tuesday, raising the death toll to 28,708. The Tuesday figure was the lowest since July 12, when Korea reported seven Covid-19 deaths.The country also added 15,476 new Covid-19 infections, including 95 cases from abroad, bringing the total caseload to 24,995
Samsung Medical Center’s Cancer Center, which ranked sixth place exceeding the U.S. Johns Hopkins Hospital and Japan’s National Cancer Center in the World’s Best Specialized Hospitals, has begun preparations to meet the new bio era.“Gone are the days when cancer hospitals only treat cancer,” General
Neofect, a company specializing in digital rehabilitation, is facing financial troubles as it failed to pay back the principal plus interest.According to the company, it has failed to pay back the principal and interest worth 3.3 billion won ($2.3 million), which is equivalent to 21.5 percent of the
The American Society of Clinical Oncology (ASCO) recently revised the guidance for the use of PARP inhibitor (PARPi) therapy in ovarian cancer, saying PARPi monotherapy is no longer recommended to treat recurrent platinum-sensitive epithelial ovarian cancer.Still, ASCO opened the possibility that PA
Baxter Korea said on Tuesday that it appointed Im Kwang-hyuk, former senior director of Baxter Korea’s Renal and Acute Business unit, as its new general manager, starting Oct. 1.Im joined Baxter’s Renal and Acute Business unit in 2018 and was in charge of peritoneal dialysis and hemodialysis. He was
Fujifilm Corp. said it has established an offshoot of Fujifilm Life Science in Korea to grow and accelerate the cell culture medium business on Oct. 4.Fujifilm plans to supply high-quality cell culture media for bioproduction and cell- and gene-based advanced therapeutics through Fujifilm Life Scien
The number of Koreans treated for pathological hair loss, including circular hair loss, exceeded 240,000 last year, recording the largest figure in the past five years. Over the past five years, 1,148,800 people have been treated for pathological hair loss.Kim Won-i of the opposition Democratic Part
As teenage drug addiction and suicide attempts rise steeply, medical narcotics prescribed by hospitals are used as their channel to drugs, a lawmaker pointed out.Rep. Suh Dong-yong of the opposition Democratic Party of Korea said so at the National Assembly Education Committee’s administrative inspe
VUNO said it has obtained the Ministry of Food and Drug Safety (MFDS) certification for Hativ P30, an artificial intelligence (AI)-based electrocardiogram (ECG) device for at-home use. The device analyzes ECG data to check normal sinus rhythm, atrial fibrillation, bradycardia, and tachycardia.The sm
Clupea, a medical big data platform company, said on Tuesday that it will jointly establish the first non-clinical big data platform based on Clinical Data Interchange Standards Consortium (CDISC) standards with the Korea Institute of Toxicology (KIT).Clupea's Medilake platform technology, which is
A recent long-term follow up study conducted by researchers at Seoul National University Hospital (SNUH) has shown that deep brain stimulation (DBS) of the subthalmic nucleus (STN) is safe and effective for patients with severe Parkinson's disease.Parkinson's disease is a degenerative brain disease
Neurophet said Thursday that the company signed a contract to provide brain disease image analysis service for the Korea National Institute of Health (NIH) to establish research data for reading and studying brain disease image data.“The project to build research data through reading brain disease i
Duchem Bio said it launched FACBC, the world’s first radiopharmaceutical used when diagnosing prostate cancer patients, in Korea.The drug, developed by Nihon Medi Physics, a Japanese pharmaceutical company, is used when conducting positron emission tomography (PET) in patients suspected of having pr
A team of mathematicians predicted that the number of new confirmed Covid-19 cases per day will drop to fewer than 4,000 in two weeks as the pandemic resurgence has turned into a declining phase.A team at the National Institute for Mathematical Science (NIMS) concluded so, after considering the amou
Aprogen has reversed its plan to acquire a cGMP plant in the United States less than a day after the initial announcement, causing repercussions.“We are examining various strategies, including the acquisition of a U.S. plant approved by the FDA, to respond to the U.S. government’s ‘made-in-America'
The International Vaccine Institute (IVI) closed the curtains on the final day of the 21st vaccinology training course with poster presentations from 11 IVI fellows followed by final lectures and a closing ceremony.On the penultimate day on Sept. 27, Korea Biomedical Review sat down with IVI fellows
Hugel said Friday that it reapplied to the U.S. Food and Drug Administration (FDA) for marketing approval for Letybo (brand name in Korea: Botulax), its botulinum toxin formulation, to treat forehead wrinkles.Hugel had sought the U.S. permit for Letybo 50 units and 100 units in March 2021.However, t